![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2020
Anzahl der Publikationen: 2
2020
Smolen, Josef S.; Sebba, Anthony; Ruderman, Eric M.; Schulze-Koops, Hendrik; Sapin, Christophe; Gellett, Amanda M.; Sprabery, Aubrey Trevelin; Li, Lingnan; de la Torre, Inmaculada; Gallo, Gaia; Liu-Leage, Soyi; Pillai, Sreekumar; Reis, Paulo und Nash, Peter
(2020):
Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naive Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study.
In: Rheumatology and Therapy, Bd. 7, Nr. 4: S. 1021-1035
Smolen, Josef S.; Mease, Philip; Tahir, Hasan; Schulze-Koops, Hendrik; de la Torre, Inmaculada; Li, Lingnan; Hojnik, Maja; Sapin, Christophe; Okada, Masato; Caporali, Roberto; Gratacos, Jordi; Goupille, Philippe; Liu Leage, Soyi; Pillai, Sreekumar und Nash, Peter
(2020):
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naive to biological disease-modifying antirheumatic drug: final results by week 52.
In: Annals of the Rheumatic Diseases, Bd. 79, Nr. 10: S. 1310-1319
[PDF, 2MB]